Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9fa13c33b79ba86e25d61d5e3cee4f2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 |
filingDate |
1992-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1993-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96ac49133c183f2532e34d3bd3054e2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_972bcd37f148b5e0be2eff002d6d8971 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25927eb4accff208aeac0dd691003b54 |
publicationDate |
1993-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5212159-A |
titleOfInvention |
Anticataract composition |
abstract |
The invention provides an anticataract composition containing a compound of the following formula <IMAGE> [wherein Rs are the same or different and each means a hydrogen atom or a lower alkyl group] or a pharmacologically acceptable salt thereof. The anticataract composition of this invention is useful for the prevention and treatment of various types of cataract including senile cataract and diabetic cataract. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2502916-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5378692-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5773652-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2502916-A1 |
priorityDate |
1991-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |